ACSL3 (acyl-CoA synthetase long chain family member 3)

2007-02-01  

Identity

HGNC
LOCATION
2q36.1
LOCUSID
ALIAS
ACS3,FACL3,LACS
FUSION GENES

Other Information

Locus ID:

NCBI: 2181
MIM: 602371
HGNC: 3570
Ensembl: ENSG00000123983

Variants:

dbSNP: 2181
ClinVar: 2181
TCGA: ENSG00000123983
COSMIC: ACSL3

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000123983ENST00000357430O95573
ENSG00000123983ENST00000357430A0A024R497
ENSG00000123983ENST00000392066O95573
ENSG00000123983ENST00000392066A0A024R497
ENSG00000123983ENST00000407441H7BYZ7
ENSG00000123983ENST00000413316C9JC11
ENSG00000123983ENST00000535678F5H062
ENSG00000123983ENST00000540115F5GWH2

Expression (GTEx)

0
10
20
30
40
50
60

Pathways

PathwaySourceExternal ID
Fatty acid biosynthesisKEGGko00061
Fatty acid degradationKEGGko00071
PPAR signaling pathwayKEGGko03320
Adipocytokine signaling pathwayKEGGko04920
Fatty acid biosynthesisKEGGhsa00061
Fatty acid degradationKEGGhsa00071
PPAR signaling pathwayKEGGhsa03320
Adipocytokine signaling pathwayKEGGhsa04920
PeroxisomeKEGGko04146
PeroxisomeKEGGhsa04146
Metabolic pathwaysKEGGhsa01100
beta-Oxidation, acyl-CoA synthesisKEGGhsa_M00086
beta-Oxidation, acyl-CoA synthesisKEGGM00086
Fatty acid metabolismKEGGhsa01212
Fatty acid metabolismKEGGko01212
MetabolismREACTOMER-HSA-1430728
Metabolism of lipids and lipoproteinsREACTOMER-HSA-556833
Fatty acid, triacylglycerol, and ketone body metabolismREACTOMER-HSA-535734
Triglyceride BiosynthesisREACTOMER-HSA-75109
Fatty Acyl-CoA BiosynthesisREACTOMER-HSA-75105
Synthesis of very long-chain fatty acyl-CoAsREACTOMER-HSA-75876
FerroptosisKEGGko04216
FerroptosisKEGGhsa04216

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
375830462023[Research advances on the role of ACSL3 in the atherosclerosis].0
375830462023[Research advances on the role of ACSL3 in the atherosclerosis].0
351827292022Activation of MAT2A-ACSL3 pathway protects cells from ferroptosis in gastric cancer.14
351827292022Activation of MAT2A-ACSL3 pathway protects cells from ferroptosis in gastric cancer.14
320343052020The ACSL3-LPIAT1 signaling drives prostaglandin synthesis in non-small cell lung cancer.27
322866042020Immunohistochemical staining reveals differential expression of ACSL3 and ACSL4 in hepatocellular carcinoma and hepatic gastrointestinal metastases.30
330307832020Metabolic enzyme ACSL3 is a prognostic biomarker and correlates with anticancer effectiveness of statins in non-small cell lung cancer.24
320343052020The ACSL3-LPIAT1 signaling drives prostaglandin synthesis in non-small cell lung cancer.27
322866042020Immunohistochemical staining reveals differential expression of ACSL3 and ACSL4 in hepatocellular carcinoma and hepatic gastrointestinal metastases.30
330307832020Metabolic enzyme ACSL3 is a prognostic biomarker and correlates with anticancer effectiveness of statins in non-small cell lung cancer.24
294508002018The endogenous subcellular localisations of the long chain fatty acid-activating enzymes ACSL3 and ACSL4 in sarcoma and breast cancer cells.25
295266652018The metabolic capacity of lipid droplet localized acyl-CoA synthetase 3 is not sufficient to support local triglyceride synthesis independent of the endoplasmic reticulum in A431 cells.11
294508002018The endogenous subcellular localisations of the long chain fatty acid-activating enzymes ACSL3 and ACSL4 in sarcoma and breast cancer cells.25
295266652018The metabolic capacity of lipid droplet localized acyl-CoA synthetase 3 is not sufficient to support local triglyceride synthesis independent of the endoplasmic reticulum in A431 cells.11
281934922017Characterization of Acyl-CoA synthetase isoforms in pancreatic beta cells: Gene silencing shows participation of ACSL3 and ACSL4 in insulin secretion.23

Citation

Dessen P

ACSL3 (acyl-CoA synthetase long chain family member 3)

Atlas Genet Cytogenet Oncol Haematol. 2007-02-01

Online version: http://atlasgeneticsoncology.org/gene/45991